HealthBlawg

David Harlow's Health Care Law Blog

    • Twitter
    • Facebook
    • LinkedIn
    • RSS
    • Email
  • About
  • Archives
  • Podcast
  • Press
  • Awards/Reviews
  • HIPAA
  • HCSM

Trepidation about transparency (in healthcare prices)? Take a closer look.

July 18, 2019

The recent Executive Order regarding health care price transparency has many folks in the health care industrial complex contemplating litigation aimed at highlighting ways in which the order may contravene existing law. It is also unpopular because list price transparency may well have the opposite of the desired effect — it may increase prices in certain circumstances rather than reduce them.

See my post on the health care pricing transparency Executive Order, and my recent Inside Digital Health column on the same topic. In a sense, the key thing to consider is that we all want to know what our bottom-line cost of health care services will be, specific to our own health plan, and our own provider. There are tools out there that can deliver this information, and the pity is that more provider organizations don’t use them. Doing so could improve customer / patient satisfaction immensely.

The administration seems to be trying to get a jump on pending congressional activity in this realm and delivering some version of transparency. In the process, the administration is garnering support from some patient advocates and generating opposition by some associations representing payers and providers.

If you are experiencing a little déjà vu, that’s understandable; the idea of making price and quality data about “shoppable” healthcare services easily available to all is by no means new. Transparency, on its face, seems like it must be a good thing. Alas, nothing is that simple. The key issues, now as always, include at least two key categories of questions:

1. Are the requirements legal? The principal issue here (assuming we get over the question of scope of executive authority and conflicts with existing law), is whether the requirements are anticompetitive or procompetitive. For example, will mandating the release of price data result in all prices for a given service rising to the level of the highest price for that service disclosed in any given market?

2. Would compliance yield meaningful data to consumers, enabling informed decision-making about healthcare services and providers? In other words, will cost and quality measures be linked in a manner that is accessible to and understandable by typical consumers? Will the information be shared in a user-friendly format, through a user-friendly channel and in a user-friendly manner?

Transparency is a hot topic, and my most recent podcast addressed the same issue from a different perspective.

Read more here.

David Harlow
The Harlow Group LLC
Health Care Law and Consulting

Filed Under: Health care policy, Health Law, Health Reform, Hospitals, Physicians

you might also like:

  1. Cost transparency – The next grand experiment in healthcare

  2. Bush signs executive order on HIT and transparency

  3. Jeanne Pinder, CEO of Clear Health Costs – Harlow On Healthcare

« Jeanne Pinder, CEO of Clear Health Costs – Harlow On Healthcare
Prescription Plumbing: Surescripts VP Andrew Mellin — Harlow On Healthcare »

Follow me on Twitter

David Harlow 💉😷 Follow 42,914 17,570

Mastodon @healthblawg@c.im #HealthCare #MedDevice #Compliance #Privacy @MyOmnipod #HIPAA #digitalhealth #HarlowOnHC #pinksocks Tweets are tweets No more no less

healthblawg
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
37m 1620898131004072027

The Harlow #Healthcare #Innovation Daily https://paper.li/healthblawg/1489156253?share_id=0e46a740-a278-11ed-ad57-fa163e65ae25 #digitalhealth #hcldr #HarlowOnHC Thanks to @Mr_Don_Auto @KardonHIPAA @vadernauts #digitalhealth #healthtech

Reply on Twitter 1620898131004072027 Retweet on Twitter 1620898131004072027 0 Like on Twitter 1620898131004072027 0 Twitter 1620898131004072027
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
4h 1620842034113175552

ICYMI> Interoperability and NLP with Kyle Silvestro, CEO of SyTrue — Harlow On Healthcare https://healthblawg.com/2022/03/interoperability-nlp-sytrue.html?utm_source=twitter&utm_medium=social&utm_campaign=ReviveOldPost #digitalhealth #hcldr #hitsm

Image for the Tweet beginning: ICYMI>  Interoperability and NLP Twitter feed image.
Reply on Twitter 1620842034113175552 Retweet on Twitter 1620842034113175552 0 Like on Twitter 1620842034113175552 0 Twitter 1620842034113175552
healthblawg avatar; David Harlow 💉😷 @healthblawg ·
7h 1620801819612946434

The latest Harlow On Health Care Daily #HarlowOnHC #digitalhealth #healthcare #innovation #privacy #hcldr Thx: @TWDigitalHealth @MrsYisWhy @thecommunityvc #digitalhealth #healthtech

Image for twitter card

Artificial intelligence model finds potential drug molecules a thousand times faster

techxplore.com The entirety of the known universe is teeming with an infinite number of molecules. But what fraction...

paper.li

Reply on Twitter 1620801819612946434 Retweet on Twitter 1620801819612946434 0 Like on Twitter 1620801819612946434 0 Twitter 1620801819612946434
Load More
Follow me on Mastodon

HIPAAtools

Hipaatools

The HIPAA Compliance Toolkit

The Walking Gallery

The Walking Gallery

Quick Links

  • Home
  • Categories
  • Archives
  • Podcast Interviews
  • HIPAAtools
  • HIPAA Compliance
  • Health Care Social Media
  • Speaking
  • In the Press
  • Blogroll

David Harlow

David Harlow

HealthcareNOW Radio

Connect with David

  • Twitter
  • Facebook
  • LinkedIn
  • RSS
  • Email
  • Subscribe
  • Contact
  • Book Me: Speaking
  • About
  • The Harlow Group LLC
Copyright © 2006–2023
HealthBlawg is a publication of The Harlow Group LLC. See Copyright notice and disclaimer.
Fair use with attribution and a link is encouraged. Click for more on David Harlow.
[footer_backtotop text="Back to top" href="#"]